Lisinopril 10 mg
Searched over 200M research papers
Summary
10 papers analyzed
These studies suggest that lisinopril 10 mg effectively reduces blood pressure, slows kidney function decline in diabetic nephropathy, and is well-tolerated, with additional benefits in combination therapies and post-myocardial infarction treatment.
Not a yes or no question
To use the Consensus Meter, try asking a simple yes or no question
Research summarized with Copilot
Beta20 papers analyzed
Lisinopril 10 mg: Efficacy, Safety, and Clinical Applications
Introduction to Lisinopril 10 mg
Lisinopril, an angiotensin-converting enzyme (ACE) inhibitor, is widely used in the management of hypertension and heart failure. This article synthesizes research findings on the efficacy, safety, and clinical applications of lisinopril at a 10 mg dosage.
Efficacy in Hypertension Management
Blood Pressure Reduction
Lisinopril 10 mg has been shown to effectively reduce blood pressure in patients with mild to moderate hypertension. In a study comparing different dosages, lisinopril 10 mg produced significant antihypertensive effects, comparable to higher doses such as 20 mg, but less than 80 mg. Another study confirmed that lisinopril 10 mg effectively lowered both systolic and diastolic blood pressure over a 24-hour period, demonstrating its long-lasting effect.
Comparison with Other Antihypertensives
Lisinopril has been compared with other antihypertensive agents such as atenolol and enalapril. In hypertensive patients with diabetic nephropathy, lisinopril 10-20 mg/day was as effective as atenolol in reducing blood pressure and slowing the decline in kidney function. Additionally, lisinopril 10 mg was found to be as effective as enalapril 10 mg in lowering blood pressure, with a potentially slower onset of action that could be clinically beneficial .
Combination Therapy
Lisinopril and Hydrochlorothiazide
Combining lisinopril with hydrochlorothiazide has been shown to enhance antihypertensive effects. A study involving a fixed-dose combination of lisinopril 10 mg and hydrochlorothiazide 25 mg demonstrated greater blood pressure reduction compared to monotherapy, without significant metabolic side effects. Pharmacokinetic studies also indicated that the combination increased the bioavailability of lisinopril, enhancing its efficacy.
Safety Profile
Side Effects and Tolerability
Lisinopril is generally well-tolerated, with a safety profile comparable to other ACE inhibitors. Common side effects include cough, which was slightly more frequent in patients taking lisinopril compared to those on placebo or other antihypertensives. In a comparative study, lisinopril 10-40 mg was associated with fewer adverse events than enalapril 5-20 mg, suggesting a favorable safety profile.
Impact on ACE2 Levels
Recent research has explored the impact of lisinopril on ACE2 levels, the receptor for SARS-CoV-2. Lisinopril 10 mg/day increased ACE2 protein levels in various tissues, which could have implications for COVID-19 transmission and pathogenesis. Interestingly, the addition of losartan prevented this increase, indicating a complex interaction between ACE inhibitors and angiotensin receptor blockers.
Clinical Applications
Heart Failure and Post-Myocardial Infarction
Lisinopril is also beneficial in managing heart failure and improving outcomes post-myocardial infarction. In patients with congestive heart failure, lisinopril 10 mg showed altered pharmacokinetics, suggesting a need for dose adjustments in this population. The GISSI-3 trial demonstrated that lisinopril, alone or in combination with glyceryl trinitrate, significantly reduced mortality and improved ventricular function after acute myocardial infarction.
Conclusion
Lisinopril 10 mg is an effective and well-tolerated option for managing hypertension, with additional benefits in heart failure and post-myocardial infarction care. Its combination with hydrochlorothiazide enhances its antihypertensive effects, and it compares favorably with other antihypertensives like atenolol and enalapril. However, its impact on ACE2 levels warrants further investigation, especially in the context of COVID-19.
Sources and full results
Most relevant research papers on this topic
